Prognostic impact of circulating HER2 extracellular domain (ECD) in women with metastatic breast cancer.

被引：0
|
作者：
Zheng, Yabing [1 ]
Shao, Xiying [1 ]
Wang, Xiaojia [1 ]
Shi, Lei [1 ]
Huang, Yuan [1 ]
机构：
[1] Zhejiang Canc Hosp, Hangzhou, Zhejiang, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e22038
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Prognostic and Predictive Value of HER2 Extracellular Domain in Metastatic Breast Cancer Treated With Lapatinib and Paclitaxel in a Randomized Phase III Study
    Finn, Richard S.
    Gagnon, Robert
    Di Leo, Angelo
    Press, Michael F.
    Arbushites, Michael
    Koehler, Maria
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (33) : 5552 - 5558
  • [42] HER2 as a prognostic factor in metastatic breast cancer treated with taxanes
    Parkes, E.
    McKenna, S. M.
    McAleer, J. J.
    Clarke, J.
    Clayton, A. J.
    James, C. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [43] The impact of HER2 positivity on survival in metastatic gastric and GEJ cancer.
    Kumar, Aalok
    Zhou, Chen
    Huntsman, David
    Kollmannsberger, Christian K.
    Gill, Sharlene
    Lim, Howard John
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [44] HER2 expression on tumor-derived extracellular vesicles and circulating tumor cells in metastatic breast cancer
    Afroditi Nanou
    Leonie Laura Zeune
    Francois-Clement Bidard
    Jean-Yves Pierga
    Leonardus Wendelinus Mathias Marie Terstappen
    Breast Cancer Research, 22
  • [45] HER2 expression on tumor-derived extracellular vesicles and circulating tumor cells in metastatic breast cancer
    Nanou, Afroditi
    Zeune, Leonie Laura
    Bidard, Francois-Clement
    Pierga, Jean-Yves
    Terstappen, Leonardus Wendelinus Mathias Marie
    BREAST CANCER RESEARCH, 2020, 22 (01)
  • [46] HER2 expression on tumor-derived extracellular vesicles and circulating tumor cells in metastatic breast cancer
    Nanou, Afroditi
    Zeune, Leonie L.
    Bidard, Francois-Clement
    Pierga, Jean-Yves
    Terstappen, Leonardus W.
    CANCER RESEARCH, 2020, 80 (16)
  • [47] Anti-HER2 treatment in advanced metastatic HER2-negative breast cancer patients with elevated serum levels of the HER2 extracellular domain and/or HER2 overexpressing circulating tumor cells.
    Kurbacher, Christian M.
    Eichler, Christian A.
    Quade, Annegret Barbara
    Kunstmann, Gerhard
    Herz, Susanne
    Kurbacher, Jutta Anna
    Warm, Mathias R.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [48] SUCCESSFUL USE OF HER2 TARGETED AGENTS IN PATIENTS WITH HEAVILY PRETREATED HER2-NEGATIVE METASTATIC BREAST CANCER PRESENTING WITH ELEVATED SERUM LEVELS OF THE HER2 EXTRACELLULAR DOMAIN AND/OR HER2 OVEREXPRESSING CIRCULATING TUMOR CELLS
    Kurbacher, Christian Martin
    Quade, Annegret
    Kunstmann, Gerhard
    Herz, Susanne
    Kurbacher, Jutta Anna
    Warm, Matthias R.
    BREAST, 2015, 24 : S70 - S70
  • [49] Serum HER2 extracellular domain as a potential alternative for tissue HER2 status in metastatic gastric cancer patients
    Peng, Zhi
    Liu, Yi
    Li, Yanyan
    Zhang, Xiaotian
    Zhou, Jun
    Lu, Ming
    Li, Qingqing
    Shen, Lin
    BIOMARKERS IN MEDICINE, 2014, 8 (05) : 663 - 670
  • [50] Prognostic value of serum level of HER-2 extracellular domain (ECD) at diagnosis of HER-2 overexpressed primary breast cancer (BC)
    Thureau, S.
    Clatot, F.
    Pille, J.
    Laberge-Le-Couteulx, S.
    Rigal, O.
    Veyret, C.
    Basuyau, J.
    Blot, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345